Skip to content
Signal Bureau What’s happening · what the record shows

FDA

U.S. Food and Drug Administration — The U.S. regulator that approves drugs, medical devices, and food safety.

Coverage of FDA is rising : 40 signals on the latest tracked day, up 21% from its three-week baseline of 33, across 15 domains (up from 11 a week ago). That makes it the #57 most-covered of the 348 concerns we track.

If FDA matters to your work, coverage is climbing off its baseline — worth a closer-than-usual look this week.

What’s changed

What the reporting says

Across 734 tracked stories from 82 outlets, reporting on FDA most often describes regulatory approvals (408), launches or releases (7), public statements (3), elections (3), meetings or visits (2), IPOs or listings (1).

It shows up alongside Drug Administration (246), U S Food (113), Cder (50), Drug Development (39), Drug Evaluation (36), Biological Products (30), AI (44), Colorectal Cancer (41).

Two steps out: Abstract (through AI, 44 shared stories on the weaker link); Anthropic (through AI, 44 shared stories on the weaker link); China (through AI, 44 shared stories on the weaker link); Citations Loading Bibliographic (through AI, 44 shared stories on the weaker link).

Tracked since Apr 6, with coverage on 108 separate days — concentrated in Pharma Regulatory.

What the crowd is pricing

Coverage momentum and market odds are separate readings — one can move without the other. A price is what the crowd believes, shown as a signal, not a forecast of ours.
Ask the engine about FDA + Track FDA for a daily read
Counts computed from our committed signal record (Jul 21 – Sep 4, 45 tracked days). Informational only — not financial, legal, or investment advice. Prediction-market prices are shown as a signal of what the crowd believes. Terms · Privacy · page rendered Sep 4, 6:57 PM PT